Research Publications
Fiser C, Crystal JS, Tevis SE, Kesmodel S, Rojas KE
Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors
Breast Cancer: Targets and Therapy (Dovepress). December 16, 2021 Issue. doi: 10.2147/BCTT.S321721
Morin C, Patel Y, Javid M, Tevis S, Fortes T, Flom P, Andaz C, Manasseh DM, Borgen P, Rojas K
Opioid-sparing multimodal analgesia protocol for lumpectomy patients results in superior postoperative pain control
Annals of Surgical Oncology. June 2, 2021 Issue. doi: 10.1245/s10434-021-09963-3
Huynh V, Colborn K, Rojas K, Christian N, Ahrendt G, Cumbler E, Schulick R, Tevis S
Evaluation of opioid prescribing preferences among surgical residents and faculty
Surgery. April 12, 2021. doi: 10.1016/j.surg.2021.02.067
Morin C, Javid M, Patel Y, Flom P, Andaz C, Manasseh DM, Borgen P, Rojas KE
Obese patients who receive an opioid-sparing enhanced recovery after surgery (ERAS) protocol are at increased risk of persistent pain after breast surgery
Annals of Surgical Oncology. November 2020 Issue (Epub 2020 Aug 4). doi: 10.1245/s10434-020-08894-9
Rojas KE, Manasseh DM, Rojas M, Mattocks A, Portnow L, Kantharia S, Zelenko N, Giuliano C, Borgen PI
The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer
Breast Cancer Research and Treatment. May 2020 Issue. doi: 10.1007/s10549-020-05666-7
Rojas KE, Fortes TA, Flom P, Manasseh DM, Andaz C, Borgen PI.
Intraoperative Ketorolac Use Does Not Increase the Risk of Bleeding in Breast Surgery
Annals of Surgical Oncology. October 2019 Issue. doi: 10.1245/s10434-019-07557-8
Rojas KE, Fortes TA, Flom P, Manasseh DM, Andaz C, Borgen PI.
Mastectomy Is No Longer an Indication for Postoperative Opioid Prescription at Discharge
American Journal of Surgery. October 2019 Issue. doi: 10.1016/j.amjsurg.2019.07.017
Rojas KE, Butler E, Gutierrez J, Kwait R, Laprise J, Scalia Wilbur J, Spinette S, Raker CA, Robison K, Legare R, Gass J, Stuckey A
Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers
Gland Surgery. 2019 May 27. doi: 10.21037/gs.2019.04.08
Rojas KE, Fortes TA, Borgen PI.
Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy.
Breast Cancer Research and Treatment. 2018 Dec 8. doi: 10.1007/s10549-018-05080-0
Rojas KE, Bilbro N, Manasseh DM, Borgen PI.
A review of pregnancy-associated breast cancer: Diagnosis, local and systemic treatment, and prognosis.
Journal of Women’s Health. 2018 Nov 27. doi: 10.1089/jwh.2018.7264
Rojas KE, Manasseh DM, Flom PL, Agbroko S, Bilbro N, Andaz C, Borgen PI.
A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge.
Breast Cancer Research and Treatment. 2018 Jun 18. doi: 10.1007/s10549-018-4859-y
Rojas K, Matthews N, Raker C, Clark M, Onstad M, Stuckey A, Gass J.
The impact of Body Mass Index (BMI) on appearance satisfaction and sexual function in breast cancer survivorship.
Journal of Cancer Survivorship. 2018;12(1):127-133. doi: 10.1007/s11764-017-0651-y
Gass J, Onstad M, Pesek S, Rojas K, et al.
Breast-specific sensuality and sexual function in cancer survivorship: does surgical modality matter?
Annals of Surgical Oncology. 2017;24(11):3133-3140. doi: 10.1245/s10434-017-5905-4
Rojas K, Onstad M, Raker C, Clark M, Stuckey A, Gass J.
The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy.
Breast Cancer Res Treat. 2017;163(2):273-279. doi: 10.1007/s10549-017-4174-z
Rojas K, Stuckey A.
Breast cancer epidemiology and risk factors.
Clinical Obstetrics and Gynecology. 2016;59(4):651-672. doi: 10.1097/GRF.0000000000000239
Barrera JG, Rojas KE, et al.
Early results after synchronous carotid stent placement and coronary artery bypass graft in patients with asymptomatic carotid stenosis.
J Vasc Surg. 2013;52(2 Supp): 58-63. doi: 10.1016/j.jvs.2012.06.116
Saint-Cyr M, Rojas K, Colohan S, Brown S.
The Role of Fat Grafting in Reconstructive and Cosmetic Breast Surgery: A Review of the Literature.
J Reconstr Microsurg. 2012;28(2): 99-110. doi: 10.1055/s-0031-1287675
Research Presentations
Click on the titles with links to see the presented poster or visual abstract.
“Mastectomy is no longer an indication for narcotic prescription at discharge”
Association of Women Surgeons Annual Conference
October 2019, San Francisco, CA
“Is breast surgery a dying specialty?”
American College of Surgeons Clinical Congress
October 2019 , San Francisco, CA
“Ketorolac does not increase the risk of bleeding in breast surgery”
American Society of Breast Surgeons Annual Meeting
May 2019, Orlando, FL
“Mastectomy is no longer an indication for postoperative narcotic prescription at discharge”
2019 Society of Surgical Oncology Annual Cancer Symposium
February 2019, San Diego CA
“A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescriptions at discharge”
American Society of Breast Surgeons 19th Annual Meeting
March 2018, Orlando FL
“The natural history of undiagnosed breast cancer in the modern era”
American Society of Breast Surgeons 19th Annual Meeting
March 2018, Orlando FL
“Tocometry Rule-in After Maternal Accident (TRAuMA): Does it change neonatal outcomes?”
American College of Obstetrics and Gynecology Annual Clinical and Scientific Meeting
May 2017, San Diego CA
“The impact of BMI on patient satisfaction with appearance and preservation of the breast’s role in intimacy before and after breast cancer surgery.”
American Society of Breast Surgeons 17th Annual Meeting
April 2016, Dallas TX
“The impact of mastectomy type on body image and sexual function.”
International Society of the Study of Women’s Sexual Health Annual Meeting
February 2016, Charleston SC
Invited Presentations
“Improving sexual function and survivorship in patients with a history of breast cancer”
ACOG District VII, IV and XI Annual Meeting
September 2019 New Orleans, LA
“Evidence based strategies for curbing perioperative opioid prescribing”
OncLive Global Expo
October 2019, Orlando, FL
“Curbing the opioid epidemic: taking steps to improve postsurgical outcomes for your patients with breast cancer”
Miami Breast Cancer Conference
March 2019, Miami, FL
“The link between hormones and breast cancer: does staying young forever come with a price?”
Maimonides Medical Center Department of Obstetrics and Gynecology Grand Rounds
January 2019, Brooklyn, NY
“Current and new concepts in cancer treatment: focus on women’s health”
Maimonides Cancer Center Hematology and Oncology CME Dinner
November 2018, Brooklyn, NY
“Sex, Drugs and Rock and Roll: Maimonides Breast Center Patient Care Innovations”
Maimonides Department of Surgery Grand Rounds
October 2018, Brooklyn NY
“Society of Surgical Oncology fellows subcommittee proposal: The fellows online collaborative”
Society of Surgical Oncology Annual Meeting
March 2018, Chicago IL
“Pregnancy-associated breast cancer: systemic therapy considerations”
Society of Surgical Oncology Breast Fellows Webinar
November 2017, Brooklyn NY
“Contralateral prophylactic mastectomy in BRCA-negative patients: improving outcomes and satisfaction in selected patients”
Maimonides Medical Center Department of Surgery Grand Rounds
October 2017, Brooklyn NY
“Special needs of the opioid-dependent pregnant patient’
Third Annual Regional Perinatal Nursing Conference
September 2016, Providence RI
“Placental abruption due to major trauma”
Invited Guest Speaker, Rhode Island Hospital Emergency Medicine Grand Rounds
August 2016, Providence RI
“The opioid-dependent patient in acute obstetrics and gynecology.”
Women & Infants’ Hospital Grand Rounds
January 2016, Providence RI